Innate Pharma S.A. (IPHA)
2.13
0.01 (0.47%)
At close: Mar 03, 2025, 3:59 PM
2.09
-1.88%
After-hours: Mar 03, 2025, 04:00 PM EST
Innate Pharma S.A. Revenue
Innate Pharma S.A. reported an annual revenue of $51.9M, reflecting a 4.56% growth. For the quarter ending June 30, 2024, Innate Pharma S.A. generated $12.35M in revenue.
Revenue (ttm)
$51.9M
Revenue Growth
4.56%
Price / Sales Ratio
4.06
Revenue / Employee
$308.93K
Employees
168
Market Cap
178.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 51.9M | +4.56% |
| Dec 31, 2022 | 49.64M | +309.83% |
| Dec 31, 2021 | 12.11M | -82.64% |
| Dec 31, 2020 | 69.77M | n/a |